Home » Topics » Regulatory » Patents

Patents
RSS

BioWorld MedTech Patent Highlights: Week 5

From Current Patent Gazette

Feb. 12, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Capella BioScience discovers anti-PD-L1 antibodies

Feb. 12, 2021

Harbin Boyicheng Biotechnology discloses new HER2-targeting nanobodies

Feb. 12, 2021

Bristol Myers Squibb synthesizes IRAK-4 inhibitors

Feb. 12, 2021

Sinocelltech discloses new anti-VEGF antibodies

Feb. 12, 2021

Wistar Institute patents new antibacterials against Pseudomonas

Feb. 12, 2021

New bispecific antibodies presented by WuXi Biologics

Feb. 11, 2021

French researchers describe PD-1/PD-L1 interaction inhibitors

Feb. 11, 2021

Kinnate Biopharma synthesizes new CDK inhibitors

Feb. 11, 2021

Korean investigators disclose tubulin polymerization inhibitors

Feb. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...